Literature DB >> 1296220

Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research.

F Dahlke1, A Lohaus, H Gutzmann.   

Abstract

The Clinical Global Impression Scale (CGI) is a recognized rating scale for global clinical judgments comprising scores for disease severity, change of disease conditions, and a so-called "efficacy index." In this report, the authors subject the CGI to a methodological analysis. Thirty-seven physicians working in psychogeriatric wards were interviewed on 12 patients each with a DSM-III diagnosis of a dementia syndrome. After the physicians made global judgments on the patients with the CGI, "personal" assessment criteria were elicited. The CGI data were correlated in the statistical analysis with the physicians' assessments of the patients on their personal criteria and on "recognized" assessment criteria obtained from DSM-III-R diagnostic criteria for dementia syndrome. Interrater reliabilities between physicians and nursing staff as well as retest reliabilities for the CGI criteria were also measured. While the CGI-severity reflects primarily the cognitive aspects of dementia, the CGI global assessment of change of the disease condition was poorly correlated with the assessments based on "personal" or the recognized DSM-III-R criteria. This was also indicated by the result that the reliability scores for CGI-severity were high and did not vary greatly, whereas the reliability scores for CGI change showed wide confidence intervals.

Entities:  

Mesh:

Year:  1992        PMID: 1296220

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  17 in total

1.  Measuring the role of psychological inflexibility in Trichotillomania.

Authors:  David C Houghton; Scott N Compton; Michael P Twohig; Stephen M Saunders; Martin E Franklin; Angela M Neal-Barnett; Laura Ely; Matthew R Capriotti; Douglas W Woods
Journal:  Psychiatry Res       Date:  2014-08-13       Impact factor: 3.222

2.  Examining DSM criteria for trichotillomania in a dimensional framework: implications for DSM-5 and diagnostic practice.

Authors:  David C Houghton; Steve Balsis; Dan J Stein; Scott N Compton; Michael P Twohig; Stephen M Saunders; Martin E Franklin; Angela M Neal-Barnett; Douglas W Woods
Journal:  Compr Psychiatry       Date:  2015-05-01       Impact factor: 3.735

3.  Augmenting Cognitive Behavior Therapy for School Refusal with Fluoxetine: A Randomized Controlled Trial.

Authors:  Glenn A Melvin; Amanda L Dudley; Michael S Gordon; Ester Klimkeit; Eleonora Gullone; John Taffe; Bruce J Tonge
Journal:  Child Psychiatry Hum Dev       Date:  2017-06

4.  Neuropsychological functioning in hoarding disorder.

Authors:  David F Tolin; Anna Villavicencio; Andrea Umbach; Matthew M Kurtz
Journal:  Psychiatry Res       Date:  2011-07-20       Impact factor: 3.222

Review 5.  Long-acting medications for the hyperkinetic disorders. A note on cost-effectiveness.

Authors:  Michael Schlander
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

6.  Increasing the Sensitivity of Measures to Change.

Authors:  Carlotta Ching Ting Fok; David Henry
Journal:  Prev Sci       Date:  2015-10

7.  An exploration of economic reasoning in hoarding disorder patients.

Authors:  David F Tolin; Anna Villavicencio
Journal:  Behav Res Ther       Date:  2011-09-28

8.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

9.  A risk-benefit assessment of pharmacological treatments for panic disorder.

Authors:  J A Bennett; M Moioffer; S P Stanton; M Dwight; P E Keck
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

Review 10.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.